3407
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Asahi Kasei Corporation is a diversified industrial group operating across three primary segments: Healthcare, Housing, and Materials. In Healthcare, the company develops pharmaceuticals, virus removal filters, and critical care devices such as automated external defibrillators and sleep apnea treatment equipment. The Housing segment focuses on residential construction, real estate, renovation, and building materials including lightweight aerated concrete and insulation. The Materials segment produces electronic materials, automotive interior components, lithium-ion battery separators, ion exchange membranes, fibers, and chemical resins. The group serves markets in Japan, the United States, Australia, and Europe through subsidiaries such as ZOLL Medical Corporation, Asahi Kasei Homes, and Asahi Kasei Electronics. Key products include medical devices, building supplies, and specialized chemical intermediates for industrial and consumer applications.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Conglomerates Homepage asahi-kasei.com
Sector Industrials IR page asahi-kasei.com
Tags
pharmaceuticals, medical devices, residential construction, building materials, electronic materials, automotive interiors, battery separators, chemicals, fibers, real estate, Asahi Kasei Pharma, Veloxis Pharmaceuticals, Calliditas Therapeutics, Kainos Life Science, Asahi Kasei Life Science, Bionova Scientific, Asahi Kasei Bioprocess Europe, ZOLL Medical Corporation, Asahi Kasei Homes, Asahi Kasei Real Estate Residence, Asahi Kasei Renovation, Focus Companies, ODC Operations, Asahi Kasei Homes Australia, NEX Building Group, Erickson Framing Operations, Asahi Kasei Building Materials, Asahi Kasei Electronics, Sage Automotive Interiors, Asahi Kasei Battery Separator, Asahi Kasei Battery Separator Canada, Asahi Kasei Honda Battery Separator, Polypore International, Asahi Kasei Advanced, Asahi Kasei Home Products, Asahi Kasei Precision Chemicals Nantong, Asahi Kasei Plastics Singapore, Asahi Kasei Plastics America, Asahi Kasei Plastics Shanghai, PS Japan, Asahi Kasei Synthetic Rubber Singapore, Tongsuh Petrochemical, Mitsubishi Chemical Asahi Kasei Ethylene, PTT Asahi Chemical, Asahi Kasei Europe, Asahi Kasei America, Asahi Kasei Holdings US, Asahi Kasei China Investment, Asahi Kasei Machinery
Press page —

Metrics

Valuation  
Market cap ¥ 2.201T
Market cap (USD) $ 13.756B
P/E 11.18
PEG —
P/BV 1.02
P/S 0.67
P/OCF 8.36
P/FCF 98.16
Dividend yield 2.6%
Turnover / mcap —
Returns  
ROE 7.8%
ROI 5.6%
ROIC 6.2%
Profit margin 5.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 34
Quality score 33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 3.075T 3.037T 2.785T 2.726T 2.461T 2.106T 2.152T 2.17T 2.042T 1.883T 1.941T 1.986T 1.898T 1.667T
Net profit 158.793B 134.996B 43.806B -91.312B 161.88B 79.768B 103.931B 147.512B 170.248B 115B 91.754B 105.652B 101.296B 53.712B
Free cash flow 92.054B 83.55B 123.346B -61.169B 13.563B 103.384B -29.99B 87.208B 153.619B 77.172B 120.704B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 1.509K 1.047K 1.112K 1.063K 1.063K 1.274K 764.9 1.142K 1.399K 1.08K 760.79 1.149K 701.89 627.86
Price performance 12m 0.44 -0.06 0.05 0 -0.17 0.67 -0.33 -0.18 0.3 0.42 -0.34 0.64 0.12 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 303B 341B 351B 331B 339B 828B 841B 930B 945B 987B
↳ YoY growth +8.1% +12.8% +2.7% -5.6% +2.3% +144.6% +1.5% +10.5% +1.6% +4.5%
↳ 5y CAGR +3.9% +22.3% +19.8% +21.5% +23.3% +23.9%
Borrowings, current (JPY) 189B 138B 195B 415B 229B 352B 360B 291B 310B 130B
Borrowings, non-current (JPY) 213B 163B 230B 289B 430B 414B 579B 626B 847B 838B
Bonds payable (JPY) 40B 20B 40B 60B 110B 160B 210B 230B 300B 280B
Lease liabilities (JPY) 772M 551M 417M 4.51B 4.8B 10.9B 35.3B 38.5B 37.6B 43.7B
Cash and deposits (JPY) 145B 156B 194B 208B 222B 245B 251B 338B 393B 377B
Intangible assets (JPY) 463B 415B 530B 685B 694B 837B 737B 755B 931B 918B
Net debt (borrowings + leases - cash) (JPY) 258B 145B 231B 500B 442B 533B 724B 617B 802B 634B
Cash flow detail
Operating cash flow (JPY) 169B 250B 212B 124B 254B 183B 90.8B 295B 301B 303B
Purchases of property, plant and equipment (JPY) -83B -82.9B -115B -138B -133B -142B -152B -148B -202B -194B
Purchases of intangible assets (JPY) -8.81B -13.4B -10.1B -16.1B -16.9B -27.5B -20.2B -24.2B -16.3B -17.4B
Change in receivables (cash effect) (JPY) -20.8B -39B 3.94B 16.9B 5.21B — 8.41B -19.1B 2.82B -12.4B
Change in inventories (cash effect) (JPY) -9.84B -11.8B -58B -52B 6.11B -73.3B -84.1B -16.3B -32.1B -76.6B
Change in payables (cash effect) (JPY) 18.6B 23B -776M -45.6B 1.71B 21.4B -7.95B 18.6B -26.7B -6.46B
Dividends paid (cash effect) (JPY) -27.9B -39.1B -51.7B -48.7B -45.8B -47.2B -48.6B -50B -50B -54.4B
Share buybacks (cash effect) (JPY) -93M -688M -40M -10B -10M -412M -1.42B -12M -30B -2.34B
Interest paid (cash effect) (JPY) -4.43B -4.74B -4.41B -4.2B -3.09B -3.65B -5.86B -7.04B -8.55B -12B
Income taxes paid (cash effect) (JPY) -61.4B -49.5B -67.7B -60.4B -70.7B -59.1B -111B -34.8B -45.5B -48.8B
Operating cash flow before change in receivables (JPY) 190B 289B 208B 108B 248B — 82.4B 314B 299B 315B
Free cash flow (OCF - PPE - intangibles) (JPY) 77.2B 154B 87.2B -30B 103B 13.6B -81.4B 123B 83.6B 92.1B
Income detail
Research and development expense (JPY) 79.6B 85.7B 90.1B 91B 89.7B 98.7B 105B 107B 111B 111B
↳ 5y CAGR +2.0% +4.4% +4.2% +3.4% +4.0% +4.3%
Total comprehensive income (JPY) 139B 178B 149B 37.2B 158B 262B 25.8B 206B 131B 293B
Comprehensive income to owners (JPY) 137B 176B 146B 35.7B 155B 258B 23.5B 203B 126B 286B
Reported Jun 28, 2017 Jun 27, 2018 Jun 25, 2019 Jun 24, 2020 Jun 25, 2021 Jun 24, 2022 Jun 25, 2024 Jun 25, 2024 Jun 25, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Asahi Kasei Corporation (ticker 3407), listed in Japan.

Company History

Date Change Detail
Sep 2, 2024 Acquired Acquired Calliditas Therapeutics AB (EDINET code 549300PVPZO8TNT76B58). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Asahi Kasei Corporation

ETF Weight in ETF Shares Market value As of
DWMF 0.50% 15,500 $ 170.808K Jun 30, 2026
DFIV 0.28% 6,209,800 $ 63.321M Nov 12, 2026
DXIV 0.16% 38,600 $ 393.604K Nov 12, 2026
AVSD 0.15% 54,700 $ 547.201K Nov 16, 2026
JSTC 0.15% 43,940 $ 442.222K Nov 17, 2026
NTSI 0.13% 60,054 $ 661.786K Jun 30, 2026
DFSI 0.13% 146,000 $ 1.489M Nov 12, 2026
DFIC 0.10% 1,463,800 $ 14.926M Nov 12, 2026
AVDE 0.08% 1,523,500 $ 15.241M Nov 16, 2026
DFAI 0.07% 1,340,052 $ 13.665M Nov 12, 2026
DFAX 0.05% 605,500 $ 6.174M Nov 12, 2026
FLSP 0.05% 42,800 $ 471.649K Jun 30, 2026
AVIV 0.04% 75,600 $ 756.277K Nov 16, 2026